PhD student at the child and adolescent psychiatry at the University of Lund and chief physician Emma Claesdotter, defended on Friday her thesis “Auditory Brainstem Response (ABR) and Cambridge Neurophysiological Test Automated Battery (CANTAB) as Objective Support in Diagnosing Childhood ADHD and ASD”. Claesdotter has examined children and adolescents with ADHD and ASD with SensoDetect
Patent- System and method for improved determination of a brain response state in Australia has now been granted and SensoDetect have achieved the registrings- and approvalpapers via the patent attorney AWA patent. The patent is valid until 2037. For further reading go to AktieTorget.
SensoDetect is discussing a collaboration with one of Bolivia’s major distributors. The distributor has contacted SensoDetect regarding cooperation during last year and a first meeting and presentation took place at the beginning of the year in Bolivia. After dialogue during the spring and summer the distributor will now visit Sweden for further talks. For
The new board and the team of SensoDetect have the last 4 months worked in a focused manner to detail the long-term strategy of the company as well as securing the funds and resources to realize the same. Thanks to this work and the strong evidence presented in the research from Uppsala University Hospital, “Auditory